Bez kategorii

The use of GLP-1 analogs is growing rapidly in obese and overweight patients who need to control body weight.

Popular obesity drug cuts the risk of heart attacks and strokes

FDA approves first ustekinumab biosimilar

Mabion purchase Cytiva Xcellerex™ XDR bioreactors with conventional mixing technology

Mabion purchase of new Cytiva Xcellerex™ XDR bioreactors